ACLX · As filed with the SEC
Arcellx cash flow statement, by quarter
The statement as Arcellx presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | Q4 2025 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 |
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net loss | — | — | — | (62,270,000) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | — | — | — | 1,576,000 |
| Non-cash operating lease expense | — | — | — | 186,000 |
| Right of use asset expensed | — | — | — | 0 |
| Amortization of premiums and discounts on marketable securities | — | — | — | (3,136,000) |
| Share-based compensation | — | — | — | 23,817,000 |
| Changes in operating assets and liabilities: | ||||
| Prepaid expenses and other current and non-current assets | — | — | — | 1,719,000 |
| Accounts payable and other current liabilities | — | — | — | 2,241,000 |
| Accrued liabilities | — | — | — | (13,231,000) |
| Operating lease liabilities | — | — | — | (659,000) |
| Contract liability to related party | — | — | — | (8,232,000) |
| Other non-current liabilities | — | — | — | (5,156,000) |
| Net cash provided by (used in) operating activities | — | — | — | (63,145,000) |
| Cash flows from investing activities | ||||
| Purchases of property and equipment | — | — | — | (780,000) |
| Purchases of marketable securities | — | — | — | (78,636,000) |
| Proceeds from maturities of marketable securities | — | — | — | 117,200,000 |
| Net cash provided by (used in) investing activities | — | — | — | 37,784,000 |
| Cash flows from financing activities | ||||
| Proceeds from exercise of stock options | — | — | — | 772,000 |
| Payments under finance leases | — | — | — | (229,000) |
| Net cash provided by (used in) financing activities | — | — | — | 543,000 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | — | — | — | (24,818,000) |
| Cash and cash equivalents and restricted cash, beginning of the year | 81,621,000 | 64,754,000 | 83,487,000 | 108,305,000 |
| Cash and cash equivalents and restricted cash, end of the year | 82,878,000 | 81,621,000 | 64,754,000 | 83,487,000 |
| Supplemental disclosures of noncash investing and financing activities: | ||||
| Purchase of property and equipment included in accounts payable and accrued liabilities | — | — | — | 227,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.